Sirolimus Treatment Of Patients With SLE
NCT04736953
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
220
Enrollment
OTHER
Sponsor class
Conditions
Lupus Erythematosus, Systemic
Interventions
DRUG:
Sirolimus
OTHER:
Placebo
Sponsor
State University of New York - Upstate Medical University